Overview

Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension

Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The study will be conducted to evaluate the efficacy and safety of topical administration of brimonidine tartrate ophthalmic suspension compared with brimonidine tartrate ophthalmic solution.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited
Treatments:
Brimonidine Tartrate
Ophthalmic Solutions
Pharmaceutical Solutions